SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 24.24 |
Enterprise Value ($M) | 18.36 |
Book Value ($M) | 29.26 |
Book Value / Share | 2.06 |
Price / Book | 0.83 |
NCAV ($M) | -16.80 |
NCAV / Share | -1.19 |
Price / NCAV | -1.44 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.13 |
Return on Assets (ROA) | -0.07 |
Return on Equity (ROE) | -0.17 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.11 |
Current Ratio | 1.28 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 35.71 |
Assets | 81.78 |
Liabilities | 52.52 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 39.55 |
Operating Income | -9.55 |
Net Income | -6.28 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 6.09 |
Cash from Investing | -0.11 |
Cash from Financing | -7.42 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Cumberland Pharmaceuticals Inc | 40.14 | -1.24 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
121 | 4,367 | 2.77 | |
1,735 | 11,264 | 15.40 | |
213 | 12,493 | 1.70 | |
4,714 | 21,653 | 21.77 | |
(click for more detail) |
Similar Companies | |
---|---|
CGON – CG Oncology, Inc. | COGT – Cogent Biosciences, Inc. |
COLL – Collegium Pharmaceutical, Inc. | CRBU – Caribou Biosciences, Inc. |
CRGX – CARGO Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io